Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Etienne Rouleau
Introduction
Etienne Rouleau is a notable inventor based in Paris, France. He has made significant contributions to the field of genetics, particularly in the detection of sequence amplifications related to the BRCA1 locus. His work has implications for understanding predispositions to certain cancers, including ovarian and breast cancer.
Latest Patents
Rouleau holds a patent titled "Methods for the detection of sequence amplification in the BRCA1 locus." This patent outlines methods for detecting amplifications of sequences in the BRCA1 locus, which are characterized by having ends that consist of or are framed with sequence stretches present at least twice in the BRCA1 locus. The amplification results in at least two or three tandem copies of the amplified sequence. The methods described also include determining predispositions to diseases or disorders associated with these amplifications.
Career Highlights
Etienne Rouleau is currently associated with Genomic Vision, a company that focuses on genomic analysis and diagnostics. His work at Genomic Vision has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in genetic testing and cancer research.
Collaborations
Rouleau has collaborated with notable colleagues such as Maurizio Ceppi and Jennifer Abscheidt. These collaborations have further enriched his research and have led to advancements in the understanding of genetic predispositions.
Conclusion
Etienne Rouleau's contributions to the field of genetics, particularly through his patent on BRCA1 locus amplifications, highlight his role as an innovative inventor. His work continues to impact the understanding of genetic predispositions to cancer, showcasing the importance of research in this critical area.